FinTech
Zelira Therapeutics: Raises $1.77m through US-based investors
Zelira Therapeutics Raises $1.77m through US-based investorsZelira Therapeutics (ZLD) raises $1.77 million to progress its clinical trials
The funds were raised via a...
FinTech
Zelira Therapeutics: Launches first product line, RAF FIVE
Zelira Therapeutics: Launches first product line, RAF FIVEZelira Therapeutics (ZLD) launches its first product line, RAF FIVE, through its dermatology subsidiary, Ilera Derm...
FinTech
Zelira Therapeutics: Launches Zenivol in Australia
Zelira Therapeutics (ZLD) has launched its proprietary cannabinoid medicine, Zenivol, in Australia
The company has received approval from the Therapeutic Goods Administration’s (TGA)...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
